Use of Cardiac Safety Data in Early Phase Trials to Supplement or Replace a Thorough QT Trial
|
Cardiac safety assessment, and particularly the evaluation of a drug’s effect on QTc, are required for all new chemical entities. This webinar will discuss strategies for collecting cardiac safety data in early phases in order to complement or help with the design of a definitive QT trial, as well as the circumstances in which early phase QT assessment may be able to replace a standard Thorough QT Trial.
Key learning points: The webinar will address:
- How early phase ECG data can help de-risk a compound
- How early phase ECG data may help with the planning of a TQT
- How early phase ECG data may replace a TQT under certain circumstances
-
Best practices for ECG collection in early phase trials
*Participants limited at our discretion.
Presenter:
|
Robert Kleiman M.D.
Chief Medical Officer & Vice President, Global Cardiology ERT |
Dr. Robert B Kleiman is a board certified cardiologist and cardiac electrophysiologist who has performed research in both basic cellular electrophysiology as well as clinical electrophysiology. Dr Kleiman completed his training at the University of Pennsylvania, and was a member of a busy cardiology practice for 12 years, before joining ERT full time in 2003. Dr. Kleiman is currently ERT’s Chief Medical Officer and Vice President, Global Cardiology. His responsibilities include, oversight of ERT’s cardiology services as well as consulting with external clients.
|
EKG is a very important tool in doing clinical research and providing clinical data.
|
Replies (0)
* = required.
|
Reach Pharma professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Learn More >> Learn how to sponsor a webinar with us? Join today and interact with a vibrant network of pharma professionals, keeping up to date with the pharma industry by accessing our wealth of Pharma articles, videos, online seminars, live conferences and more. Sign Up Today! |
| Pharma IQ, a division of IQPC 2013 All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy. Careers With IQPC | Contact Us | Unsubscribe to Bizo | About Us | Cookie Policy |
|
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!